Liposomal curcumin-bioavailability, effects and comparison with infusions

liposomy biodostępność kurkumina – technologia liposomalna

Many bioactive compounds of natural origin show limited absorption when used in conventional oral forms. This is particularly true for substances that are poorly soluble in water or prone to degradation in the digestive system.

This group includes, among others:

  • curcumin and other polyphenols,
  • resveratrol,
  • quercetin,
  • plant triterpenes (e.g. betulin),
  • coenzyme Q10,
  • vitamin C (in higher doses),
  • turmeric extracts.

Duration of action and practical considerations

It is worth looking at this topic from a practical perspective — considering both duration of action and overall cost.

A standard intravenous curcumin infusion, depending on the dose, typically costs in the range of £500–1300 per session. A relatively high dose is administered at once, resulting in a rapid increase in blood concentration.

This makes intravenous delivery a valuable tool in situations where immediate support is needed.

At the same time, pharmacokinetic data shows that the presence of such compounds in plasma is relatively short-lived — usually measured in hours rather than days. The body quickly metabolizes and eliminates excess amounts.

As a result, in order to maintain an effect, infusions are typically performed periodically, often 1–2 times per week.

Liposomal approach – sustained exposure

Liposomal delivery follows a different model.

Instead of a single high peak, smaller doses are administered regularly, allowing for a more stable level of the compound over time.

From a cellular perspective, the key factor is not the peak concentration at a given moment, but the duration of exposure.

This is why liposomal forms are particularly relevant for long-term processes such as:

  • regeneration,
  • modulation of inflammatory processes,
  • metabolic support.

Complementary approach

In this context:

Intravenous infusion can be seen as a rapid, high-impact intervention.
Liposomal delivery provides a complementary, continuous approach that supports the body between such interventions.

Rather than replacing one another, these approaches can function within the same model — addressing different physiological needs.

Research direction

To further evaluate the performance of liposomal formulations, biodistribution and pharmacokinetic studies are planned in cooperation with an academic institution.

The objectives include:

  • analysis of plasma persistence time,
  • observation of tissue distribution,
  • comparison of release profiles versus conventional forms.

These results will allow future communication to be based strictly on measurable data rather than assumptions.

Summary

Scientific evidence suggests that liposomal systems:

  • improve the bioavailability of bioactive compounds,
  • modify their pharmacokinetics,
  • extend their presence in the body,
  • enable more stable and predictable biological activity.

In practice, this represents a different approach to working with the body — less intervention-based, more systemic and continuous.

Intravenous infusions provide rapid support when needed.
Liposomal technology supports longer-term physiological processes through sustained exposure.

For a more detailed explanation of liposomal mechanisms and their application in herbal formulations, see:
Liposomal herbal supplements

Practical example

One practical application of this approach is liposomal curcumin. By protecting the molecule and improving biodistribution, it enables more stable and predictable effects at lower, regularly administered doses.

This is particularly relevant in long-term support strategies, where continuous cellular exposure is more important than short-term peak effects.

See product:
Liposomal curcumin 10ml

More about nanoemulsion technology:
nanoemulsion-50-nm

References

  1. Hickey et al. (2020) – Liposomal vitamin C: improved bioavailability and plasma concentrations
    PubMed ID: 32901526
  2. Nauman et al. (2024) – Pharmacokinetics and cellular uptake of liposomal vitamin C
    PMC: PMC11519160
  3. Sercombe et al. (2015) – Advances and challenges of liposome assisted drug delivery
    Journal of Controlled Release
  4. Akbarzadeh et al. (2013) – Liposome: classification, preparation, and applications
    Nanoscale Research Letters
  5. Immordino et al. (2006) – Stealth liposomes: review of the basic science, rationale, and clinical applications
    International Journal of Nanomedicine

.

If this topic is important to you

Leave your email – I’ll let you know when there are new articles
and materials on the site.

No spam. Only valuable content.

Please enable JavaScript in your browser to complete this form.
Pola wyboru
Facebook
WhatsApp
Twitter
LinkedIn
Pinterest